These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28183357)

  • 1. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study.
    Romano E; Bellando-Randone S; Manetti M; Bruni C; Lepri G; Matucci-Cerinic M; Guiducci S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S148-52. PubMed ID: 26088817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.
    Romano E; Rosa I; Fioretto BS; Giuggioli D; Manetti M; Matucci-Cerinic M
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI125-SI137. PubMed ID: 35900177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.
    Chora I; Romano E; Manetti M; Mazzotta C; Costa R; Machado V; Cortez A; Bruni C; Lepri G; Guiducci S; De Paulis A; Soares R; Matucci-Cerinic M
    J Rheumatol; 2017 Aug; 44(8):1190-1197. PubMed ID: 28507177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
    D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
    Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.
    Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide.
    Villano M; Borghini A; Manetti M; Gabbrielli E; Rossi A; Sestini P; Milia A; Nacci F; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    Arthritis Res Ther; 2013 Aug; 15(4):R90. PubMed ID: 23962393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
    Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
    Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
    J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoglein-2-integrin Beta-8 interaction regulates actin assembly in endothelial cells: deregulation in systemic sclerosis.
    Giusti B; Margheri F; Rossi L; Lapini I; Magi A; Serratì S; Chillà A; Laurenzana A; Magnelli L; Calorini L; Bianchini F; Fibbi G; Abbate R; Del Rosso M
    PLoS One; 2013; 8(7):e68117. PubMed ID: 23874518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.